Conversion Notice and Total Voting Rights | 29-May-2024 | 07:00 | RNS |
Holding(s) in Company | 11-Apr-2024 | 11:44 | RNS |
Conversion Notice & Total Voting Rights | 05-Apr-2024 | 07:00 | RNS |
Half-year Report | 22-Mar-2024 | 07:00 | RNS |
Holding(s) in Company | 18-Mar-2024 | 11:36 | RNS |
New research project and CSO to return to academia | 18-Mar-2024 | 07:00 | RNS |
Conversion Notice and Total Voting Rights | 12-Mar-2024 | 07:00 | RNS |
Notice of Results | 08-Mar-2024 | 09:43 | RNS |
Conversion notice and alternative financing | 28-Feb-2024 | 12:41 | RNS |
Positive Interim AxisBiotix Acne study results | 27-Feb-2024 | 07:00 | RNS |
Dermatonics to launch Once Heel Balm in AMEA | 20-Feb-2024 | 07:00 | RNS |
Conversion Notice and Total Voting Rights | 09-Feb-2024 | 07:00 | RNS |
Dermatonics Full Year trading update | 06-Feb-2024 | 07:31 | RNS |
Completion of Acquisition of Dermatonics | 26-Jan-2024 | 07:00 | RNS |
Acquisition of Dermatonics | 25-Jan-2024 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 9.75p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 29.00p |
52 Week Low | 7.25p |
Volume | 768,418 |
Shares Issued | 202.26m |
Market Cap | £19.72m |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
16:18 | 34,150 @ 9.70p |
16:11 | 35,051 @ 9.70p |
15:51 | 1,862 @ 9.55p |
13:45 | 16,082 @ 9.72p |
12:52 | 17,000 @ 9.55p |
CEO | Stuart Ashman |
CFO | Manprit Singh Randhawa |
You are here: research